Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) rose 18.1% during mid-day trading on Thursday. The company traded as high as $13.39 and last traded at $13.39. Approximately 16,695 shares changed hands during trading, an increase of 105% from the average session volume of 8,145 shares. The stock had previously closed at $11.3374.
Santen Pharmaceutical Stock Up 10.5%
The firm has a 50 day moving average price of $11.11 and a 200 day moving average price of $11.50.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription medicines and other products used to diagnose and treat eye diseases.
Its product portfolio includes ophthalmic treatments for conditions such as glaucoma, dry eye, allergic eye disease, ocular infections and retinal disorders. Santen also develops therapies for other vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen serves patients and medical professionals through operations and commercial activities in Japan and international markets, including parts of Asia, Europe and other regions.
Further Reading
- Five stocks we like better than Santen Pharmaceutical
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
